The overall aim of this project is to characterize factors that act on neuronal stem or progenitor cells in the adult and aging brain and influence or regulate endogenous adult neurogenesis. Knowledge about the biology of these processes will be relevant for future therapeutic approaches to Alzheimer's Disease (AD) and other neurodegenerative disorders, in that manipulation of neuronal stem or progenitor cells in situ night allow neuronal replacement and cellular and structural regeneration. The underlying rationale is that identification of regulatory mechanisms under physiological conditions will provide the necessary tools to manipulate neuronal stem or progenitor cells for therapeutic goals. In this project we propose to investigate molecular events and constraints that regulate neurogenesis in the adult and aged rodent and primate dentate molecular events and constraints that regulate neurogenesis in the adult and aged rodent and primary dentate gyrus. Glutamatergic fibers project to the dentate gyrus and damage to these fibers has been reported to influence neurogenesis. We will therefore also investigate in transgenic animals the role of glutamate receptors in neurogenic regulation. The specific objectives of this project are: 1) Determine if and to what extent hippocampal neurogenesis occurs in adult primates. 2) Determine the effects of long-term environmental stimulation on neurogenesis in the aging brain of mice. 3) Determine the role of learning and physical activity as key factors in environmental stimulation of adult hippocampal neurogenesis. 4) Characterize the role of glutamatergic system n the regulation of neurogenesis in the adult and aging hippocampus.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005131-17S1
Application #
6398527
Study Section
Project Start
2000-06-01
Project End
2001-03-31
Budget Start
Budget End
Support Year
17
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Golde, Todd E; DeKosky, Steven T; Galasko, Douglas (2018) Alzheimer's disease: The right drug, the right time. Science 362:1250-1251
Reas, Emilie T; Hagler Jr, Donald J; White, Nathan S et al. (2018) Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin 20:883-891
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Graves, Lisa V; Holden, Heather M; Van Etten, Emily J et al. (2018) New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. J Int Neuropsychol Soc 24:833-841
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Fong, Lauren K; Yang, Max M; Dos Santos Chaves, Rodrigo et al. (2018) Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-? clearance in human astrocytes. J Biol Chem 293:11341-11357
Edmonds, Emily C; Ard, M Colin; Edland, Steven D et al. (2018) Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y) 4:11-18
Spencer, Brian; Brüschweiler, Sven; Sealey-Cardona, Marco et al. (2018) Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathol 136:69-87

Showing the most recent 10 out of 914 publications